Pulse Biosciences (PLSE) Revenue (2021 - 2026)

Pulse Biosciences (PLSE) posted quarterly Revenue of $86000.0 for Q3 2025, down 67.55% quarter-over-quarter from $265000.0 in Q2 2022.

Pulse Biosciences (PLSE) Revenue (2021 - 2026) Analysis & Trends

Pulse Biosciences' Revenue history runs 3 years deep, the most recent figure standing at $86000.0 for Q3 2025.

In Q3 2025, Revenue changed N/A year-over-year to $86000.0; the TTM figure through Sep 2025 stood at $86000.0 (changed N/A YoY), while the FY2022 annual figure was $700000.0, down 50.0% from the prior year.
Revenue for Q3 2025 stood at $86000.0, down from $265000.0 in the prior quarter.
The five-year high for Revenue was $826000.0 in Q4 2021, with the low at $86000.0 in Q3 2025.
The 3-year median for Revenue is $444000.0 (2022), against an average of $439000.0.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Revenue (Qtr)
1	Intuitive Surgical	134.69 Bn	129.47 Bn	1.96 Bn	2.89 Bn
2	Becton Dickinson	52.58 Bn	51.71 Bn	2.32 Bn	4.98 Bn
3	Alcon	35.75 Bn	34.39 Bn	1.68 Bn	2.82 Bn
4	Resmed	33.89 Bn	32.42 Bn	861.22 Mn	1.46 Bn
5	Medline	29.13 Bn	26.45 Bn	2.22 Bn	7.69 Bn
6	West Pharmaceutical Services	24.97 Bn	24.53 Bn	329.20 Mn	872.30 Mn
7	Solventum	15.40 Bn	14.99 Bn	1.29 Bn	2.21 Bn
8	Cooper Companies	14.84 Bn	14.70 Bn	735.40 Mn	1.08 Bn
9	Baxter International	13.61 Bn	11.46 Bn	1.03 Bn	2.96 Bn
10	Pulse Biosciences	3.46 Bn	3.46 Bn	161,000.00	434,000.00

Download Data